Additional Information
Market: AIM
Sector: Healthcare, Equipment & Services
EPIC: DEMG
Latest Price: 28.13p  (0.46% Ascending)
52-week High: 29.75p
52-week Low: 15.25p
Market Cap: 42.21M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Deltex Medical Group
www.deltexmedical.com

Deltex Medical manufactures and markets the CardioQ-ODMÔ system. CardioQ-ODM changes the way doctors care for surgical patients allowing them to recover faster and leave hospital sooner and in better health than they otherwise would do. The performance of the system has been validated through independently conducted, randomised controlled clinical trials and is being translated into routine clinical practice in leading hospitals around the world.

Pdf

Deltex Medical Group’s CardioQ product selected for US research programme

22nd Feb 2012, 7:48 am by Jamie Ashcroft Hospitals run by the Premier Healthcare Alliance will trial the firm’s CardioQ oesophageal doppler monitoring device as part of the research programme.

Deltex Medical Group (LON:DEMG) told investors that it has been picked to take part in a research project in the United States.

Hospitals run by the Premier Healthcare Alliance will trial the firm’s CardioQ oesophageal doppler monitoring device as part of the research programme.

According to Deltex the programme, called the Premier QUEST® Comparative Effectiveness & Innovation Program (QCEIP), helps the American healthcare community better understand patient outcomes associated with the use of certain medical products. 

"Being selected to work with Premier on the QUEST Comparative Effectiveness & Innovation Program creates a major opportunity for Deltex Medical,” said chief executive Ewan Phillips

“We expect to be able to demonstrate and then promote the value of CardioQ-ODM within a collaboration of some of the USA's leading hospitals, including some of our existing accounts. 

“Success has the potential to accelerate the wide-scale adoption of CardioQ-ODM in the USA."

Deltex says the research programme leverages data from America’s most comprehensive repository of clinical, financial and outcomes information to test, validate and substantiate the concepts put forward by suppliers of new healthcare products. 

The Premier Healthcare Alliance aims to improve performance across more than 2,500 American hospitals.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.